An observational study in Management and Epidemiology of Patients Admitted in ICU, sponsored by Heart Care Foundation. Completed at 109 sites in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-02.
Sponsored by Heart Care Foundation · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Multicentre, national, observational, retrospective and prospective study.
The BLITZ-COVID19 study aims at describing the epidemiology of admissions to Italian Cardiology Intensive Care Units in the COVID-19 infection pandemia, the main aspects of the clinical management of inpatients, their short-term outcome, the absorption of resources related to their admission.
The BLITZ-COVID19 study, aims at describing the epidemiology of admissions to Italian Cardiology Intensive Care Units .
The study is observational, multicentre, national and involves the collection of clinical data, both retrospectively and prospectively, using a web-based system. In conducting the study, no drugs are tested, nor are diagnostic tests or non-pharmacological therapies performed other than those that each participating cardiologist decides to perform following the rules of normal clinical practice. Diagnostic procedures and pharmacological and non-pharmacological therapies habitually prescribed for cardiovascular pathologies, which are the object of hospitalization, and those used in the event of a COVID-19 infection, will be recorded in the database.
Heart Care Foundation is the lead sponsor of 22 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients aged ≥18 years admitted with any diagnoses to ICU in the specified periods of 30 days each.
Retrospecitve phase:(March 1-30, 2020 in the Northern or Centre-North regions; March 15-April 13, 2020 in the Southern or Ventre_South Regions and island.
Perspective phase (depending by the IRB approval) in the following periods:
November 9-December 8, 2020; November 23-December 22, 2020; January 11-February 9, 2021.
(Retrospective study) or in the
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
- All patients aged ≥18 years admitted with any diagnosis to one of the participating ICU
Exclusion Criteria:
- Refuse to signe consent
Cardiology Intensive Care Unit admission
Impact that COVID-19 infection may have had on the in-hospital mortality
Impact that COVID-19 infection may have had on the in-hospital mortality of the various clinical conditions admitted to ICU
Time frame: Enrollment
Epidemiology and management of patients admitted to ICU
The different diagnoses of discharge from the ICU and their frequency will be described. All hospitalized cardiac and non-cardiac pathologies will be listed, with particular reference to any COVID-19 infection.
Time frame: Enrollment
Management of patients admitted to ICU
Description of the main therapeutic decision in patients hospitalized for the most relevant pathologies
Time frame: Enrollment
Showing the first 100 of 109 sites. Choose a country and city above to see the rest.
Plan to share: Undecided — Still to be decided
Ran from Nov 2020 to primary completion in Feb 2021, 3 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Heart Care Foundation